UNH vs MRNA
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRNA |
|---|---|---|
| Price | $427.89 | $67.27 |
| Market cap | $388.59B | $26.69B |
| P/E ratio | 32.3 | — |
| ROE | 12.18% | -36.56% |
| Profit margin | 2.68% | -143.55% |
| Revenue growth | 2.00% | 260.20% |
| Dividend yield | 2.17% | — |
| Beta | 0.65 | 1.03 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRNA in plain English
- UNH is the bigger company — about 14.6× the market cap of MRNA.
- UNH earns a higher return on equity (12% vs -37%).
- MRNA is growing revenue faster (260% vs 2%).
- UNH pays a dividend (2.17%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.